A Case-Based Oncology Perspective to Biomarker Testing in Advanced NSCLC
Mark A. Socinski, MD
Executive Medical Director,
Florida Hospital Cancer Institute,
Join Dr. Socinski as he uses a case-based approach to highlight the importance of biomarker-driven clinical decision making in advanced non-small cell lung cancer (NSCLC), and reviews best practices for optimizing biomarker testing.